Acceleron Pharma Stock rises 7% after a $11bn deal with Merck
On Monday, rumors surfaced that Acceleron Pharma (XLRN) was in discussions to be bought by a ...
Read more
On Monday, rumors surfaced that Acceleron Pharma (XLRN) was in discussions to be bought by a ...
Read more